Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Berlin Cures (Group)

Berlin Cures Holding AG, a privately-held company founded in 2014 and based in Zug, Switzerland, is establishing a new generation of treatments based on research of autoimmune diseases conducted at the renowned Charité Berlin and at the Max-Delbrueck-Center in Berlin for over a quarter of a century. The focus is to develop treatments for diseases with autoimmune pathology in which functional autoantibodies directed against G-protein-coupled receptors of different types play a significant role. With over 1000 different sub-types, the family of G-protein-receptors constitutes the largest protein super-family with the physiological ability to sense molecules outside the cell. Berlin Cures holds the IP for a platform of aptamers that bind to and neutralize these functional autoantibodies, which play an important role in the pathophysiology of several autoimmune-diseases. Recent studies involving heart failure, pulmonary hypertension, chronic fatigue syndrome, pre-eclampsia and a significant number of other diseases have shown that these functional autoantibodies play a highly underestimated role in disease development and sustenance. Neutralizing these autoantibodies can lead to substantial improvements in treatment. *

 

Period Start 2014-09-01 splitoff
  Predecessor Charité – Universitätsmedizin Berlin (Charité University Hospital)
Products Industry aptamer drug
  Industry 2 BC007 (Berlin Cures)
Person Person Müller, Johannes (Berlin Cures 201409– CEO + Co-founder)
     
Region Region Berlin
  Country Germany
  Street 59-61 Knesebeckstr.
  City 10719 Berlin
  Tel +49-30-88017160
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Berlin Cures Holding AG. (8/22/18). "Press Release: Berlin Cures Announces Successful Completion of Phase 1 Study of BC 007 for the Treatment of Cardiomyopathy". Zug.
     
   
Record changed: 2023-12-30

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Berlin Cures (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top